Maria Carolina Clares Ramalho

NRF2 signaling drives chemoresistance in NSCLC and glioblastoma

Although great advances have been made in cancer treatment, lung cancer and glioblastoma patients continue to present a dismal prognosis, mainly due to drug resistance. Evidence suggests that NRF2 and glutathione (GSH) play a fundamental role in chemotherapy resistance. Notably,...